The renin-angiotensin system and the heart: Beyond 2000

Heart

Volumn 76, Issue 3 SUPPL. 3, 1996, Pages 98-103

  Morgan, T ^a   Brunner, H R ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; LISINOPRIL; LOSARTAN; QUINAPRIL; RENIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; GENETIC MARKER; HEART INFARCTION; HEMODYNAMICS; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0029953394     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.76.3_suppl_3.98     Document Type: Review

References (42)

1. Morgan T, Davis JM. Renin secretion at the individual nephron level. Pflugers Arch 1975;359:23-31.
2. Mendelsohn FA. A method for measurement of angiotensin II in tissues and its application to rat kidney. Clin Sci Mol Med 1976;51:111-25.
3. Harris PJ, Young JA. Dose-dependent stimulation and inhibition of proximal tubular sodium reabsorption by angiotensin II in the rat kidney. Pflugers Arch 1977;367: 295-7.
4. Campbell DJ, Kladis A, Duncan AM. Nephrectomy, converting enzyme inhibition, and angiotensin peptides. Hypertension 1993;22:513 22.
5. Dzau VJ, Gibbons GH, Cooke JP, Omoigui N. Vascular biology and medicine in the 1990s: scope, concepts, potentials, and perspectives. Circulation 1993;87:705 19.
6. Lindpaintner K, Ganten D. The cardiac renin angiotensin system. An appraisal of present experimental and clinical evidence. Circ-Res 1991;68:905 21.
7. Naruse M, Takii Y, Inagami T. Renin exists in high concentration in the adrenal gland of the rat. Biomed Research 1981;2:583-4.
8. Ganten D, Hermann K, Bayer C, Unger T, Lang RE. Angiotensin synthesis in the brain and increased turnover in hypertensive rats. Science 1982;222:869 71.
9. von Lutterotti N, Catanzaro DF, Sealey JE, Laragh JH. Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. Circulation 1994;89:458 70.
10. Danser AHJ, Schalekamp MADH. Is there an internal cardiac renin angiotensin system? Heart 1996;76(suppl 3): 28 32 (this issue).
11. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995;95:651 7.
12. Chiu AT, Roscoe WA, McCall DE, Timmermans PB. Angiotensin II-I receptor mediates both vasocontriction and hypertrophic responses in rat aortic smooth muscle cells. Receptor 1991;1:33-40.
13. Harris PJ, Hiranyachattada S, Antoine AM, Walker L, Reilly AM, Eitle E. Regulation of renal tubular sodium transport by angiotensin II and atrial natriuretic factor. Clin Exp Pharmacol Physoil (in press).
14. Zhang Y, Morgan T. Effects of enalapril and Dup753 on renin synthesis in mice with one hydronephrotic kidney. Clin Exp Pharmacol Physiol 1994;21:133 5.
15. Gupta P, Franco-Saenz R, Mulrow PJ. Locally generated angiotensin II in the adrenal gland regulates basal, corticotropin-, and potassium-stimulated aldosterone secretion. Hypertension 1995;25:443 8.
16. Ishihata A, Endoh M. Species-related differences in inotropic effects of angiotensin II in mammalian ventricular muscle: receptors, subtypes and phosphoinositide hydrolysis. Br J Pharmacol 1995;114:447 53.
17. Miyata S, Haneda T. Hypertrophic growth of cultured neonatal rat heart cells mediated by type 1 angiotensin II receptor. Am J Physiol 1994;266:H2443 51.
18. Yamazaki T, Komuro I, Shiojimo I, Yazaki Y. The reninangiotensin system and cardiac hypertrophy. Heart 1996;76(suppl 3):33-5 (this issue)
19. Griffin SA, Brown WC, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, et al. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991;17:626 35.
20. Dostal DE, Baker KM. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Mediation by the AT1 receptor. Am J Hypertens 1992;5:276 80.
21. Kim S, Ohta K, Hamaguchi A, Yukimura T, Miura K, Iwao H. Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension 1995;25:1252 9.
22. Linz W, Schölkens BA, Ganten D. Converting enzyme-inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens (Theor Pract) 1989;A11:1325 50.
23. Linz W, Schaper J, Wiemer G, Albus U, Schölkens BA. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats. Br J Pharmacol 1992;107:970 5.
24. Rhaleb NE, Yang XP, Scicli AG, Carretero OA. Role of kinins and nitric oxide in the antihypertrophic effect of ramipril. Hypertension 1994;23:865 8.
25. Gohlke P, Linz W, Schölkens BA, Kuwer I, Bartenbach S, Schnell A, et al. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. Hypertension 1994;23:411-8.
26. Ruzicka M, Yuan B, Harmsen H, Leenen FH. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker. Circulation 1993;87:921-30.
27. Ruzicka M, Leenen FH. Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy, Cirulation 1995;91:16-19.
28. Iwai N, Shimoike H, Kinoshita M. Cardiac renin-angiotensin system in the hypertrophied heart. Circulation 1995;92:2690 6.
29. Cushman DW, Wang FL, Fung WC, Harvey CM, DeForrest JM. Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs. Am J Hypertens 1989;2:294-306.
30. Yuan BX, Leenen FH. Dietary sodium intake and left ventricular hypertrophy in normotensive rats. Am J Physiol 1991;261:H1397-401.
31. Harrap SB, Nicolaci JA, Doyle AE. Persistent effects on blood pressure and renal haemodynamics following chronic angiotensin converting enzyme inhibition with perindopril. Clin Exp Pharmacol Physiol 1986;13:753 65.
32. Harrap SB, Van der Merwe WM, Griffin SA, Macpherson F, Lever AF. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 1990;16:603-14.
33. Di Nicolantonio R, Spargo S, Morgan TO. Prenatal high salt diet increases blood pressure and salt retention in teh spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 1987;14:233-5.
34. Di Nicolantonio R, Silvapulle MJ, Spargo MJ, Morgan TO. High salt diet decreases longevity in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 1988;15:357-9.
35. Harrap SB. Cardiovascular disease and genetics of the renin-angiotensin system. Heart 1996;76(suppl 3): 13-7 (this issue).
36. Dluhy RG, Lifton RP. Glucocorticoid-remediable aldosteronism. Endocrinol Metab Clin North Am 1994;23: 285-97.
37. Ueda S, Morton JJ, Elliot HL, Connell JMC. Enhanced pressor response to angiotensin I in normotensive males with DD type of angiotensin converting enzyme gene. J Hypertens 1994;12:1324.
38. Tiret L, Bonnardeaux A, Poirier O, Ricard S, MarquesVidal P, Evans A, et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994;344:910-3.
39. Cambien F, Poirier O, Lecerf L, Evans A, Cambon JP, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-44.
40. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325: 293-302.
41. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ, Cuddy TE, et al. The SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992;327:669-77.
42. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821 8.